Abstract
Introduction

Angioimmunoblastic T-cell lymphoma (AILT) was first described in 1974 by Frizzera et al as a reactive disease, angioimmunoblastic lymphadenopathy with dysproteinaemia (1). AILT was recently grouped into nodal mature T-cell lymphoma, shows a relationship to Epstein-Bar virus (EBV) infection, and is sometimes complicated with pleural effusion (2, 3). Although the character of tumor cells in AILT has not been established, a microdissection study on lymph nodes showed that CD4-positive T-cells aberrantly expressing CD10 have monoclonal T-cell receptor bands in polymerase chain reaction, indicating the possible tumor cells (4). Due to the difficulty of obtaining a histological differential diagnosis mostly from reactive lymphoid hyperplasia, it is sometimes necessary to repeat biopsies of lymph nodes to obtain a diagnosis.
In this study, we report a case of AILT which developed with lymphocytic bilateral pleural effusion followed by systemic lymphadenopathy. (Fig. 4) , but not HHV-8 or HTLV-1. -c h a i 
After the diagnosis, the patient's treatment included the administration of 30 mg of prednisolone. Because of his age and his general condition, we did not choose to do chemotherapy, such as the combination therapy of cyclophosphamide, doxorubicin, vincristine and prednisolone, which have been reported to have effect on AILT (3). Pleurodesis was performed three times on his left chest. These treatments led to the temporary alleviation of the patient's symptoms. He died four months after admission because of disseminated intravascular coagulation.
Discussion
AILT is a mature T-cell lymphoma representing 2.35% of lymphomas in Japan (5). Its clinical manifestation is represented by skin rash and polyclonal hypergammaglobulinemia, in addition to symptoms typical of lymphomas such as high fever, night sweating, weight loss and generalized lymphadenopathy. The differential diagnosis of AILT includes autoimmune disorder, viral infections, Castleman's disease, atypical T-zone hyperplasia, peripheral T-cell lymphoma of other types, T-cell/histiocyte-rich large B-cell lymphoma and Hodgkin lymphoma. Diagnosis of AILT is difficult in cases in which cellular atypia is minimal. Furthermore, the use of
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